Condition: HIV Infection · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among infants living with HIV.
This description comes directly from the study's public registry record.
Anne Coletti, MS · 919-627-6445 · acoletti@fhi360.org
Always discuss trial participation with your own doctor first.
| 4601, University of California, San Diego Clinical Research Site | La Jolla, California, United States | Completed |
| 5048, University of Southern California Clinical Research Site | Los Angeles, California, United States | Recruiting |
| 5112, David Geffen School of Medicine at UCLA Clinical Research Site | Los Angeles, California, United States | Recruiting |
| 5052, University of Colorado, Denver Clinical Research Site | Aurora, Colorado, United States | Recruiting |
| 5055, South Florida CDTC Fort Lauderdale Clinical Research Site | Fort Lauderdale, Florida, United States | Completed |
| 5051, University of Florida Center for HIV/AIDS Research, Education and Service (UF CARES) Clinical Research Site | Jacksonville, Florida, United States | Recruiting |
| 5127, Pediatric Perinatal HIV Clinical Research Site | Miami, Florida, United States | Withdrawn |
| Emory University School of Medicine NICHD CRS | Atlanta, Georgia, United States | Withdrawn |
| 5083, Rush University Cook County Hospital Clinical Research Site | Chicago, Illinois, United States | Completed |
| 4001, Lurie Children's Hospital of Chicago Clinical Research Site | Chicago, Illinois, United States | Recruiting |
| 5092, Johns Hopkins Clinical Research Site | Baltimore, Maryland, United States | Recruiting |
| Boston Medical Center Ped. HIV Program NICHD CRS | Boston, Massachusetts, United States | Withdrawn |
+ 34 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.